Project leaders: Benjamin Gmeiner, Claudia Quiering, Bjoern Eskofier
Project members: Tatiana Merzhevich
Start date: 15.12.2023
End date: 21.12.2026
Funding source: Novartis Pharma GmbH
Abstract
Clinical trials are essential for developing safe and effective medical treatments, yet they face high failure rates, extensive timelines, and substantial costs. Current Artificial Intelligence (Al) and data analytics tools have the potential to transform clinical research, improve its efficiency, optimize outcomes, and reduce expenses to advance medical research. This project aims to modernize clinical research and accelerate the development of new treatments by leveraging Al and Machine Learning (ML) algorithms and to align clinical practice with evolving healthcare landscapes to ensure efficient and cost-effective solutions for overall health and well-being.
Privacy Settings
Our website uses cookies and similar technologies.
Some cookies are necessary for visiting this website, i.e. essential. Otherwise, without these cookies, your end device would not be able to remember your privacy choices, for example.
If you agree, we also use cookies and data to measure your interactions with our website or to integrate external media (e.g. videos).
You can view and withdraw your consent at any time at Privacy policy. On the site you will also find additional information about the cookies and technologies used.
Here you will find an overview of all cookies used. You can give your consent to whole categories or display further information and select certain cookies.
